ZEO ScientifiX (OTCQB: ZEOX) supports Peru pediatric burn reconstruction mission
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
ZEO ScientifiX, Inc. filed a report describing a humanitarian initiative supported by the company. Medical Advisory Board member Dr. Constantino Mendieta joined a 10-day pediatric burn reconstruction mission in Cusco, Peru, where he used products that had been donated to him by ZEO ScientifiX.
During the mission, approximately 80 children were evaluated and nearly 40 reconstructive surgeries were performed over six days at the Regional Hospital of Cusco. ZEO frames this product donation as part of a broader commitment to physician-led care, regenerative medicine education, and expanding access to advanced therapeutic options for patients in need.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 8.01, 9.01
2 items
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Mission duration: 10 days
Children evaluated: approximately 80 children
Reconstructive surgeries: nearly 40 surgeries
+1 more
4 metrics
Mission duration
10 days
Length of humanitarian medical mission in Cusco, Peru
Children evaluated
approximately 80 children
Pediatric burn survivors evaluated during the mission
Reconstructive surgeries
nearly 40 surgeries
Reconstructive procedures performed over six days
Child patients treated
approximately 38 child patients
Patients receiving specialized reconstructive care for severe burns
Key Terms
regenerative biologics, clinical-stage biopharmaceutical company, Medical Advisory Board, forward-looking statements, +1 more
5 terms
regenerative biologics medical
"a biologics research and products company dedicated to advancing the science and development of regenerative biologics products"
clinical-stage biopharmaceutical company financial
"ZEO ScientifiX, Inc. (OTCQB: ZEOX) is an SEC-reporting, clinical-stage biopharmaceutical company"
A clinical-stage biopharmaceutical company develops drugs or medical therapies that are being tested in people in formal clinical trials but do not yet have any approved, marketed products. For investors, these firms behave like prototype makers: their value depends heavily on trial results and regulatory decisions, so they can swing widely on a single study, consume cash while testing, and offer either large upside if trials succeed or big downside if they fail.
Medical Advisory Board other
"ZEO’s Medical Advisory Board member Constantino Mendieta, MD, recently participated in a humanitarian medical mission"
forward-looking statements regulatory
"Certain statements contained in this press release should be considered forward-looking statements within the meaning of the Securities Act of 1933"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
regenerative medicine education medical
"commitment to supporting physician-led care, regenerative medicine education, and initiatives that expand access"
FAQ
What did ZEOX disclose in its latest 8-K filing?
ZEO ScientifiX disclosed that a Medical Advisory Board member, Dr. Constantino Mendieta, joined a humanitarian mission in Cusco, Peru, using products donated by the company. The effort focused on reconstructive care for children recovering from severe burn injuries.
How did ZEO ScientifiX (ZEOX) support the pediatric burn mission in Peru?
ZEO ScientifiX supported the mission by donating its products for use by Medical Advisory Board member Dr. Mendieta. These regenerative biologics products were used in reconstructive procedures for child burn survivors at the Regional Hospital of Cusco during the 10-day mission.
How many children were treated during the ZEOX-supported mission in Cusco?
During the mission, approximately 80 children were evaluated and nearly 40 reconstructive surgeries were performed over six days. The work focused on pediatric burn survivors, aiming to improve function, mobility, confidence, and quality of life for the young patients.
What broader commitments did ZEO ScientifiX highlight in this 8-K?
ZEO ScientifiX highlighted that this product donation is part of a broader commitment to supporting physician-led care, regenerative medicine education, and initiatives that expand access to advanced therapeutic options for patients who might otherwise lack specialized reconstructive treatment.
Who is Dr. Constantino Mendieta in relation to ZEOX?
Dr. Constantino Mendieta is a member of ZEO ScientifiX’s Medical Advisory Board and is known for innovations in reconstructive surgery. He contributes to physician education and scientific initiatives for the company and participated in the pediatric burn reconstruction mission in Cusco, Peru.
What does ZEO ScientifiX (OTCQB: ZEOX) focus on as a business?
ZEO ScientifiX is a clinical-stage biopharmaceutical company focused on research, development, and manufacturing of regenerative biologics. Operating from Nova Southeastern University’s Center of Collaborative Research, it supplies clinicians with biologics and regenerative therapies designed to support clinical excellence and practice growth.